p57Kip2 is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factorβ1

被引:77
作者
Urano, T
Yashiroda, H
Muraoka, M
Tanaka, K
Hosoi, T
Inoue, S
Ouchi, Y
Tanaka, K
Toyoshima, H
机构
[1] Metropolitan Inst Mes Sci, Dept Tumor Biochem, Bunkyo Ku, Tokyo 1138613, Japan
[2] Metropolitan Inst Mes Sci, Dept Chemotherapy & CREST, Japan Sci & Technol Corp, Bunkyo Ku, Tokyo 1138613, Japan
[3] Univ Tokyo, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan
关键词
D O I
10.1074/jbc.274.18.12197
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclin-dependent kinase inhibitory proteins are negative regulators of the cell cycle. Although all the cyclin-dependent kinase inhibitory proteins may be involved in cell cycle control during a differentiation process, only p57(Kip2) is shown to be essential for embryonic development. However, the role of p57 in the control of the cell cycle is poorly understood. Using osteoblasts derived from the calvaria of rat fetus, we show that p57 is accumulated in cells starved by low serum. Cyclin-dependent kinase 2 activity was suppressed in these cells with a significant amount bound to p57, Treatment of the cells with transforming growth factor beta 1 dramatically reduced the amount of p57, resulting in an activation of cyclin-dependent kinase 2 activity and the stimulation of cell proliferation. The decrease in p57 was inhibited by treating the cells with proteasome inhibitors, Z-Leu-Leu-Leu-aldehyde or lactacystin, but not with Z-Leu-Leu-aldehyde, which is an inhibitor of calpain, indicating that p57 is degraded through the proteasome pathway. p57 was also shown to be ubiquitinated in vitro, Because transforming growth factor beta 1 not only stimulates the growth but also inhibits the differentiation of the cells in this system, our results may suggest a possible involvement of p57 in the control of osteoblastic cell proliferation and differentiation.
引用
收藏
页码:12197 / 12200
页数:4
相关论文
共 41 条
[1]   TGF-BETA ALTERS GROWTH AND DIFFERENTIATION-RELATED GENE-EXPRESSION IN PROLIFERATING OSTEOBLASTS IN-VITRO, PREVENTING DEVELOPMENT OF THE MATURE BONE PHENOTYPE [J].
BREEN, EC ;
IGNOTZ, RA ;
MCCABE, L ;
STEIN, JL ;
STEIN, GS ;
LIAN, JB .
JOURNAL OF CELLULAR PHYSIOLOGY, 1994, 160 (02) :323-335
[2]  
CENTRELLA M, 1987, J BIOL CHEM, V262, P2869
[3]  
CHAN FKM, 1995, MOL CELL BIOL, V15, P2682
[4]   TRANSFORMING GROWTH FACTOR-BETA INHIBITS FORMATION OF OSTEOCLAST-LIKE CELLS IN LONG-TERM HUMAN MARROW CULTURES [J].
CHENU, C ;
PFEILSCHIFTER, J ;
MUNDY, GR ;
ROODMAN, GD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (15) :5683-5687
[5]   Shared role of the pRB-related p130 and p107 proteins in limb development [J].
Cobrinik, D ;
Lee, MH ;
Hannon, G ;
Mulligan, G ;
Bronson, RT ;
Dyson, N ;
Harlow, E ;
Beach, D ;
Weinberg, RA ;
Jacks, T .
GENES & DEVELOPMENT, 1996, 10 (13) :1633-1644
[6]   Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation [J].
Durand, B ;
Gao, FB ;
Raff, M .
EMBO JOURNAL, 1997, 16 (02) :306-317
[7]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[8]   The role of protein stability in the cell cycle and cancer [J].
Elledge, SJ ;
Harper, JW .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1998, 1377 (02) :M61-M70
[9]   Role of cyclin A and p27 in anti-IgM-induced G(1) growth arrest of murine B-cell lymphomas [J].
Ezhevsky, SA ;
Toyoshima, H ;
Hunter, T ;
Scott, DW .
MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (04) :553-564
[10]   INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN [J].
FENTEANY, G ;
STANDAERT, RF ;
LANE, WS ;
CHOI, S ;
COREY, EJ ;
SCHREIBER, SL .
SCIENCE, 1995, 268 (5211) :726-731